EP3266795A1 — Method for detecting a fig-ros fusion polynucleotide
Assigned to Cell Signaling Technology Inc · Expires 2018-01-10 · 8y expired
What this patent protects
The present application provides methods for detecting a FIG-ROS fusion polynucleotide in a biological sample from a subject having liver cancer. In some embodiments, the FIG-ROS fusion proteins comprise part of the FIG protein fused to the kinase domain of the ROS kinase.
USPTO Abstract
The present application provides methods for detecting a FIG-ROS fusion polynucleotide in a biological sample from a subject having liver cancer. In some embodiments, the FIG-ROS fusion proteins comprise part of the FIG protein fused to the kinase domain of the ROS kinase.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.